NASDAQ:PETS PetMed Express (PETS) Stock Price, News & Analysis $1.91 -0.05 (-2.55%) Closing price 07/13/2026 04:00 PM EasternExtended Trading$1.91 0.00 (0.00%) As of 07/13/2026 05:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock About PetMed Express Stock (NASDAQ:PETS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get PetMed Express alerts:Sign Up Key Stats Today's Range$1.87▼$2.0250-Day Range$1.68▼$2.3752-Week Range$1.57▼$4.10Volume323,754 shsAverage Volume1.75 million shsMarket Capitalization$40.82 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingReduce Company Overview PetMed Express, Inc. operates as an online and catalog-based pet pharmacy and retail supplier under the 1-800-PetMeds brand name. The company distributes prescription and non‐prescription medications, nutritional supplements, flea and tick control products, and a range of pet health supplies directly to consumers. Through its licensed veterinary pharmacy in Delray Beach, Florida, PetMed Express fills orders for dogs, cats and other companion animals, offering both branded and generic products alongside its own private‐label formulations. Founded in 1996 by Marc Puleo, PetMed Express built its business on the premise of convenience and cost savings for pet owners seeking reliable access to veterinary medications. The company launched its initial public offering in 2000 and has since developed an in‐house team of veterinarians and pharmacy professionals to review prescriptions and provide customer support. With a multi‐channel approach that includes online ordering, telephone service and direct mail catalogs, PetMed Express seeks to simplify the process of obtaining essential pet health products. PetMed Express primarily serves customers across the United States, with select offerings available in Canada. Its operations center around a fulfillment facility in Florida, supported by a network of third‐party carriers for nationwide delivery. The company is led by its founder and Chief Executive Officer, Marc Puleo, who oversees strategy and business development alongside a management team experienced in pharmaceutical distribution and e-commerce. PetMed Express continues to focus on expanding its product portfolio, enhancing digital capabilities and maintaining compliance with regulatory standards in veterinary pharmacy.AI Generated. May Contain Errors. Read More PetMed Express Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks23rd Percentile Overall ScorePETS MarketRank™: PetMed Express scored higher than 23% of companies evaluated by MarketBeat, and ranked 177th out of 200 stocks in the retail/wholesale sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.2 / 5Analyst RatingReduce Consensus RatingPetMed Express has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and 1 sell rating.Amount of Analyst CoveragePetMed Express has only been the subject of 2 research reports in the past 90 days.Read more about PetMed Express' stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth28.57% Earnings GrowthEarnings for PetMed Express are expected to grow by 28.57% in the coming year, from $0.07 to $0.09 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of PetMed Express is -0.69, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of PetMed Express is -0.69, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioPetMed Express has a P/B Ratio of 1.41. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about PetMed Express' valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted7.67% of the float of PetMed Express has been sold short.Short Interest Ratio / Days to CoverPetMed Express has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in PetMed Express has recently increased by 164.16%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldPetMed Express does not currently pay a dividend.Dividend GrowthPetMed Express does not have a long track record of dividend growth.Dividend SustainabilityBased on EPS estimates, PetMed Express will have a dividend payout ratio of 1,000.00% in the coming year. This indicates that PetMed Express may not be able to sustain their current dividend. News and Social Media2.1 / 5News Sentiment0.43 News SentimentPetMed Express has a news sentiment score of 0.43. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.77 average news sentiment score of Retail/Wholesale companies.News Coverage This WeekMarketBeat has tracked 2 news articles for PetMed Express this week, compared to 2 articles on an average week.Search Interest5 people have searched for PETS on MarketBeat in the last 30 days. This is an increase of 400% compared to the previous 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, PetMed Express insiders have not sold or bought any company stock.Percentage Held by Insiders1.30% of the stock of PetMed Express is held by insiders.Percentage Held by Institutions73.33% of the stock of PetMed Express is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about PetMed Express' insider trading history. Receive PETS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PetMed Express and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PETS Stock News HeadlinesPetMed Express, Inc. (NASDAQ:PETS) Short Interest Update1 hour ago | americanbankingnews.comPetMed Express considers revised buyout bid as Singapore-based investor presses for saleJuly 1, 2026 | bizjournals.comRead now. Do not delete. You’ve been warned.Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” Porter Stansberry exposes how the convergence of three immense forces is about to rewrite everything about the American way of life: how you work, save, invest… it’s all about to change. | Porter & Company (Ad)PetMed Express to Evaluate Revised Takeover Offer From SilverCapeJune 30, 2026 | marketwatch.comPetMed Express, Inc. Confirms Receipt of Unsolicited, Non-Binding, and Conditional Acquisition Proposal from SilverCape Investments LimitedJune 30, 2026 | globenewswire.comPetMed Express Shares Rise on Revised $3-a-Share Buyout Offer From SilverCapeJune 29, 2026 | marketwatch.comActivist investor slams PetMed board for 'stunning destruction' of shareholder valueJune 29, 2026 | msn.comSilverCape revises proposal to acquire PetMed ExpressJune 29, 2026 | seekingalpha.comSee More Headlines PETS Stock Analysis - Frequently Asked Questions How have PETS shares performed this year? PetMed Express' stock was trading at $3.20 at the beginning of 2026. Since then, PETS shares have decreased by 40.3% and is now trading at $1.91. How were PetMed Express' earnings last quarter? PetMed Express, Inc. (NASDAQ:PETS) released its earnings results on Tuesday, June, 2nd. The company reported ($0.19) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.18) by $0.01. The firm earned $42.82 million during the quarter, compared to analysts' expectations of $52 million. PetMed Express had a negative net margin of 32.00% and a negative trailing twelve-month return on equity of 76.86%. Read the conference call transcript. How do I buy shares of PetMed Express? Shares of PETS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of PetMed Express own? Based on aggregate information from My MarketBeat watchlists, some other companies that PetMed Express investors own include Meta Platforms (META), NVIDIA (NVDA), Intel (INTC), Pfizer (PFE), Walt Disney (DIS), Ford Motor (F) and PayPal (PYPL). Company Calendar Last Earnings6/02/2026Today7/13/2026Next Earnings (Estimated)7/27/2026AGM 20268/11/2026Fiscal Year End3/31/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (3m+) 1-Year History Jul 25 Oct 25 Jan 26 Apr 26 Jul 26 PETS's financial health is in the Red zone, according to TradeSmith. PETS has been in this zone for over 3 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorRetail/Wholesale Industry INTERNET COMMERCE Sub-IndustryInternet Retail Current SymbolNASDAQ:PETS CIK1040130 Webwww.1800petmeds.com Phone(561) 526-4444Fax561-526-4445Employees210Year Founded1996Profitability EPS (Trailing Twelve Months)($2.75) Trailing P/E RatioN/A Forward P/E Ratio27.29 P/E GrowthN/ANet Income-$57.29 million Net Margins-32.00% Pretax Margin-32.04% Return on Equity-76.86% Return on Assets-31.67% Debt Debt-to-Equity RatioN/A Current Ratio0.84 Quick Ratio0.58 Sales & Book Value Annual Sales$179.02 million Price / Sales0.23 Cash Flow$0.30 per share Price / Cash Flow6.34 Book Value$1.35 per share Price / Book1.41Miscellaneous Outstanding Shares21,370,000Free Float21,094,000Market Cap$40.82 million OptionableOptionable Beta0.77 Social Links The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (NASDAQ:PETS) was last updated on 7/14/2026 by MarketBeat.com Staff. From Our PartnersSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredTrump’s $250 Bill – See ImmediatelyFormer Goldman Sachs VP Dr. David Eifrig is warning that July 28 could trigger the biggest wealth reset in mod...Stansberry Research | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredThey told you not to miss this oneThe largest companies in the SP 500 are now more overvalued relative to fundamentals than they were at the abs...Thor Metals | SponsoredForget SpaceX, this is Elon’s Next BreakthroughJeff Brown and Marc Chaikin - two investors who called Nvidia a decade ago - say Elon Musk's newly filed AI pa...Brownstone Research | SponsoredWhen I found Rolls-Royce under $2, most people thought I was crazyIn 2022, Karim Rahemtulla recommended Rolls-Royce when it traded under $2. The stock climbed more than 1,100% ...Monument Traders Alliance | SponsoredBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...Chaikin Analytics | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PetMed Express, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PetMed Express With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PETS Stock Alerts